1Other quality system
The implementation of a self-inspection program was inadequate.
Inspection Record
Pillar5 Pharma Inc. — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
2Labeling and packaging
The positive identification of each batch of drug after the packaging and/or after it was received on the importer's premises was inadequate.
3Other quality system
The availability, implementation, and/or quality of the written sanitation program was inadequate.
4Other quality system
The premises were not laid out and/or designed to ensure that production areas were adequately isolated and segregated.
About this record
Extracted automatically from the document of the Health Canada inspection on 2023-06-28. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
